Skip to content

Dallas Mayor Tom Leppert Discusses Diabetes Study Being Conducted at UT-Southwestern Medical Center

December 30, 2010

Mayor Leppert joined representatives from the Juvenile Diabetes Research Foundation and UT-Southwestern Medical Center in recognizing study on potential novel diabetes therapy

Laura Leppert and Mayor Tom Leppert

On Tuesday, December 21, 2010, Dallas Mayor Tom Leppert and Laura Leppert led a news conference with the JDRF Greater Dallas Chapter at Dallas City Hall to showcase JDRF’s partnership with Amylin Pharmaceuticals in a research study investigating Metreleptin as a potential therapy to improve blood glucose control in type 1 diabetes. This study is being based at UT-Southwestern Medical Center with Dr. Roger Unger, Dr. Abhimanyu Garg and Dr. Gregory Clark. Read more about this diabetes research.

Dr. Gregory Clark, Cliff Harris, Dr. Unger

Joining the Mayor and Mrs. Leppert was Dallas Cowboy legend and longtime JDRF supporter Cliff Harris (whose father had diabetes) along with Dallas City Councilwoman Delia Jasso; Dr. Roger Unger, Touchstone/West Distinguished Chair in Diabetes Research at UT-Southwestern Medical Center; Dr. Gregory Clark, an endocrinologist and assistant professor at UT-Southwestern who has type 1 diabetes; Jim Baldwin, president of the Juvenile  Diabetes Research Foundation (JDRF) Dallas board of directors (and parent to a daughter with type 1 diabetes); and Michael Keith, treasurer of the JDRF board and lives with type 1 diabetes.

Cliff Harris, Jim Baldwin, Dr. Unger, Mayor Tom Leppert, and Michael Keith

View photos from the news conference

Councilwoman Delia Jasso

A special thank you to Mayor Tom Leppert and Laura Leppert for being such great partners and advocates for diabetes research and JDRF. We are honored to have Mrs. Leppert serving on the JDRF Greater Dallas board of directors and as our Honorary School Walk Chair. JDRF would also like to thank all of the speakers for their participation in this news conference and for helping JDRF bring awareness to this great study taking place in Dallas, Texas.

About JDRF

JDRF is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump – each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. To help improve the lives of people with type 1 diabetes while working toward a cure, one of JDRF’s research goals is to support research to develop products that can dramatically improve blood glucose control in people with type 1 diabetes so they can live healthier lives with less risk of developing disease-related complications.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.5 billion to diabetes research, including more than $107 million last year. More than 80 percent of JDRF’s expenditures directly support research and research-related education.


To learn more about the JDRF Dallas chapter, visit our JDRF Dallas website!

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: